Correlation Between Innate Pharma and Orchestra BioMed
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Innate Pharma and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Orchestra BioMed.
Diversification Opportunities for Innate Pharma and Orchestra BioMed
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Innate and Orchestra is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Innate Pharma i.e., Innate Pharma and Orchestra BioMed go up and down completely randomly.
Pair Corralation between Innate Pharma and Orchestra BioMed
Given the investment horizon of 90 days Innate Pharma is expected to under-perform the Orchestra BioMed. But the stock apears to be less risky and, when comparing its historical volatility, Innate Pharma is 1.16 times less risky than Orchestra BioMed. The stock trades about -0.08 of its potential returns per unit of risk. The Orchestra BioMed Holdings is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 667.00 in Orchestra BioMed Holdings on August 28, 2024 and sell it today you would lose (110.00) from holding Orchestra BioMed Holdings or give up 16.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Innate Pharma vs. Orchestra BioMed Holdings
Performance |
| Timeline |
| Innate Pharma |
| Orchestra BioMed Holdings |
Innate Pharma and Orchestra BioMed Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Innate Pharma and Orchestra BioMed
The main advantage of trading using opposite Innate Pharma and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.| Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals |
| Orchestra BioMed vs. BCE Inc | Orchestra BioMed vs. CECO Environmental Corp | Orchestra BioMed vs. Ironveld Plc | Orchestra BioMed vs. Freedom Internet Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |